nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—Exemestane—Prednisone—systemic scleroderma	0.195	1	CrCrCtD
Conjugated Estrogens—ABCC11—Methotrexate—systemic scleroderma	0.0788	0.131	CbGbCtD
Conjugated Estrogens—SLCO3A1—Methotrexate—systemic scleroderma	0.0541	0.0898	CbGbCtD
Conjugated Estrogens—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.0481	0.0799	CbGbCtD
Conjugated Estrogens—ABCG2—Leflunomide—systemic scleroderma	0.036	0.0599	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—systemic scleroderma	0.0346	0.0574	CbGbCtD
Conjugated Estrogens—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.028	0.0465	CbGbCtD
Conjugated Estrogens—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0246	0.0409	CbGbCtD
Conjugated Estrogens—SLCO1A2—Prednisone—systemic scleroderma	0.0237	0.0394	CbGbCtD
Conjugated Estrogens—SLC22A6—Captopril—systemic scleroderma	0.0229	0.038	CbGbCtD
Conjugated Estrogens—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0223	0.037	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—systemic scleroderma	0.0217	0.0361	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—systemic scleroderma	0.0193	0.0321	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—systemic scleroderma	0.0178	0.0296	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—systemic scleroderma	0.0166	0.0276	CbGbCtD
Conjugated Estrogens—CYP1A2—Pentoxifylline—systemic scleroderma	0.0156	0.0259	CbGbCtD
Conjugated Estrogens—CYP1A2—Leflunomide—systemic scleroderma	0.0149	0.0247	CbGbCtD
Conjugated Estrogens—ABCB1—Lisinopril—systemic scleroderma	0.0136	0.0226	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—systemic scleroderma	0.0133	0.0222	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—systemic scleroderma	0.0119	0.0198	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—systemic scleroderma	0.0112	0.0187	CbGbCtD
Conjugated Estrogens—SLC22A8—Methotrexate—systemic scleroderma	0.0104	0.0172	CbGbCtD
Conjugated Estrogens—ABCB1—Captopril—systemic scleroderma	0.0102	0.0169	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—systemic scleroderma	0.00988	0.0164	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—systemic scleroderma	0.00893	0.0148	CbGbCtD
Conjugated Estrogens—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00803	0.0133	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—systemic scleroderma	0.00723	0.012	CbGbCtD
Conjugated Estrogens—ABCB1—Prednisone—systemic scleroderma	0.00642	0.0107	CbGbCtD
Conjugated Estrogens—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00481	0.00799	CbGbCtD
Conjugated Estrogens—CYP3A4—Prednisone—systemic scleroderma	0.00385	0.00639	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—systemic scleroderma	0.00322	0.00535	CbGbCtD
Conjugated Estrogens—SLC51B—digestive system—systemic scleroderma	0.00155	0.0608	CbGeAlD
Conjugated Estrogens—SLC51B—tendon—systemic scleroderma	0.00148	0.0579	CbGeAlD
Conjugated Estrogens—SLC51B—lung—systemic scleroderma	0.0013	0.0508	CbGeAlD
Conjugated Estrogens—SLC51A—digestive system—systemic scleroderma	0.00111	0.0436	CbGeAlD
Conjugated Estrogens—SLC51A—tendon—systemic scleroderma	0.00106	0.0415	CbGeAlD
Conjugated Estrogens—SLC51A—lung—systemic scleroderma	0.00093	0.0364	CbGeAlD
Conjugated Estrogens—ESR1—blood vessel—systemic scleroderma	0.000892	0.0349	CbGeAlD
Conjugated Estrogens—SLC10A1—digestive system—systemic scleroderma	0.000722	0.0283	CbGeAlD
Conjugated Estrogens—SLCO1B3—lung—systemic scleroderma	0.000691	0.0271	CbGeAlD
Conjugated Estrogens—ESR2—connective tissue—systemic scleroderma	0.000668	0.0261	CbGeAlD
Conjugated Estrogens—SLC22A11—digestive system—systemic scleroderma	0.000659	0.0258	CbGeAlD
Conjugated Estrogens—ESR2—smooth muscle tissue—systemic scleroderma	0.000611	0.0239	CbGeAlD
Conjugated Estrogens—COMT—smooth muscle tissue—systemic scleroderma	0.000583	0.0228	CbGeAlD
Conjugated Estrogens—COMT—skin of body—systemic scleroderma	0.000575	0.0225	CbGeAlD
Conjugated Estrogens—SLCO3A1—tendon—systemic scleroderma	0.000568	0.0222	CbGeAlD
Conjugated Estrogens—SLCO4A1—digestive system—systemic scleroderma	0.000544	0.0213	CbGeAlD
Conjugated Estrogens—SLCO3A1—lung—systemic scleroderma	0.000499	0.0195	CbGeAlD
Conjugated Estrogens—ESR2—digestive system—systemic scleroderma	0.000483	0.0189	CbGeAlD
Conjugated Estrogens—SLCO1B1—digestive system—systemic scleroderma	0.000479	0.0187	CbGeAlD
Conjugated Estrogens—COMT—digestive system—systemic scleroderma	0.00046	0.018	CbGeAlD
Conjugated Estrogens—ESR1—connective tissue—systemic scleroderma	0.000458	0.0179	CbGeAlD
Conjugated Estrogens—SLCO4A1—lung—systemic scleroderma	0.000454	0.0178	CbGeAlD
Conjugated Estrogens—ABCC3—digestive system—systemic scleroderma	0.000454	0.0178	CbGeAlD
Conjugated Estrogens—COMT—tendon—systemic scleroderma	0.000438	0.0171	CbGeAlD
Conjugated Estrogens—SLCO2B1—digestive system—systemic scleroderma	0.000423	0.0166	CbGeAlD
Conjugated Estrogens—ESR1—smooth muscle tissue—systemic scleroderma	0.000419	0.0164	CbGeAlD
Conjugated Estrogens—ESR2—lung—systemic scleroderma	0.000403	0.0158	CbGeAlD
Conjugated Estrogens—SLCO2B1—tendon—systemic scleroderma	0.000403	0.0158	CbGeAlD
Conjugated Estrogens—SLCO1A2—digestive system—systemic scleroderma	0.00039	0.0152	CbGeAlD
Conjugated Estrogens—COMT—lung—systemic scleroderma	0.000384	0.015	CbGeAlD
Conjugated Estrogens—ABCC3—lung—systemic scleroderma	0.000379	0.0148	CbGeAlD
Conjugated Estrogens—ABCC4—digestive system—systemic scleroderma	0.000375	0.0147	CbGeAlD
Conjugated Estrogens—ABCC2—digestive system—systemic scleroderma	0.000363	0.0142	CbGeAlD
Conjugated Estrogens—ABCC4—tendon—systemic scleroderma	0.000357	0.014	CbGeAlD
Conjugated Estrogens—SLCO2B1—lung—systemic scleroderma	0.000354	0.0138	CbGeAlD
Conjugated Estrogens—ABCB1—blood vessel—systemic scleroderma	0.000352	0.0138	CbGeAlD
Conjugated Estrogens—ABCC2—tendon—systemic scleroderma	0.000345	0.0135	CbGeAlD
Conjugated Estrogens—ESR1—digestive system—systemic scleroderma	0.00033	0.0129	CbGeAlD
Conjugated Estrogens—SLCO1A2—lung—systemic scleroderma	0.000325	0.0127	CbGeAlD
Conjugated Estrogens—ABCC4—lung—systemic scleroderma	0.000313	0.0123	CbGeAlD
Conjugated Estrogens—ABCC1—tendon—systemic scleroderma	0.000304	0.0119	CbGeAlD
Conjugated Estrogens—ESR1—lung—systemic scleroderma	0.000276	0.0108	CbGeAlD
Conjugated Estrogens—ABCC1—lung—systemic scleroderma	0.000267	0.0104	CbGeAlD
Conjugated Estrogens—CYP1A2—digestive system—systemic scleroderma	0.000255	0.00997	CbGeAlD
Conjugated Estrogens—ABCG2—lung—systemic scleroderma	0.000221	0.00865	CbGeAlD
Conjugated Estrogens—CYP1A2—lung—systemic scleroderma	0.000213	0.00833	CbGeAlD
Conjugated Estrogens—CYP3A4—digestive system—systemic scleroderma	0.000184	0.00722	CbGeAlD
Conjugated Estrogens—ABCB1—digestive system—systemic scleroderma	0.000131	0.00511	CbGeAlD
Conjugated Estrogens—Infection—Lisinopril—systemic scleroderma	0.00011	0.000619	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00011	0.000617	CcSEcCtD
Conjugated Estrogens—Somnolence—Mycophenolic acid—systemic scleroderma	0.000109	0.000615	CcSEcCtD
Conjugated Estrogens—ABCB1—lung—systemic scleroderma	0.000109	0.00427	CbGeAlD
Conjugated Estrogens—Shock—Lisinopril—systemic scleroderma	0.000109	0.000613	CcSEcCtD
Conjugated Estrogens—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000611	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000108	0.000609	CcSEcCtD
Conjugated Estrogens—Tachycardia—Lisinopril—systemic scleroderma	0.000108	0.000608	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Azathioprine—systemic scleroderma	0.000108	0.000607	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Azathioprine—systemic scleroderma	0.000108	0.000607	CcSEcCtD
Conjugated Estrogens—Skin disorder—Lisinopril—systemic scleroderma	0.000108	0.000605	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000107	0.000602	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Captopril—systemic scleroderma	0.000107	0.000602	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000107	0.000601	CcSEcCtD
Conjugated Estrogens—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000601	CcSEcCtD
Conjugated Estrogens—Irritability—Methotrexate—systemic scleroderma	0.000107	0.0006	CcSEcCtD
Conjugated Estrogens—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000107	0.0006	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000106	0.000597	CcSEcCtD
Conjugated Estrogens—Fatigue—Mycophenolic acid—systemic scleroderma	0.000106	0.000596	CcSEcCtD
Conjugated Estrogens—Mood swings—Methotrexate—systemic scleroderma	0.000106	0.000596	CcSEcCtD
Conjugated Estrogens—Nausea—Mometasone—systemic scleroderma	0.000106	0.000595	CcSEcCtD
Conjugated Estrogens—Anorexia—Lisinopril—systemic scleroderma	0.000106	0.000594	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000105	0.000593	CcSEcCtD
Conjugated Estrogens—Weight increased—Prednisone—systemic scleroderma	0.000105	0.000592	CcSEcCtD
Conjugated Estrogens—Pain—Mycophenolic acid—systemic scleroderma	0.000105	0.000591	CcSEcCtD
Conjugated Estrogens—Constipation—Mycophenolic acid—systemic scleroderma	0.000105	0.000591	CcSEcCtD
Conjugated Estrogens—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000591	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000588	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Prednisone—systemic scleroderma	0.000104	0.000587	CcSEcCtD
Conjugated Estrogens—Cough—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000584	CcSEcCtD
Conjugated Estrogens—Hypotension—Lisinopril—systemic scleroderma	0.000103	0.000582	CcSEcCtD
Conjugated Estrogens—Dizziness—Captopril—systemic scleroderma	0.000103	0.000582	CcSEcCtD
Conjugated Estrogens—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000579	CcSEcCtD
Conjugated Estrogens—Depression—Prednisone—systemic scleroderma	0.000103	0.000578	CcSEcCtD
Conjugated Estrogens—Urticaria—Leflunomide—systemic scleroderma	0.000102	0.000576	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Leflunomide—systemic scleroderma	0.000102	0.000573	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Leflunomide—systemic scleroderma	0.000102	0.000573	CcSEcCtD
Conjugated Estrogens—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000102	0.000572	CcSEcCtD
Conjugated Estrogens—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000569	CcSEcCtD
Conjugated Estrogens—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000569	CcSEcCtD
Conjugated Estrogens—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000569	CcSEcCtD
Conjugated Estrogens—Myocardial infarction—Prednisone—systemic scleroderma	0.000101	0.000569	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000101	0.000569	CcSEcCtD
Conjugated Estrogens—Breast disorder—Methotrexate—systemic scleroderma	0.000101	0.000568	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000101	0.000567	CcSEcCtD
Conjugated Estrogens—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000567	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Azathioprine—systemic scleroderma	0.000101	0.000566	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000101	0.000565	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000565	CcSEcCtD
Conjugated Estrogens—Insomnia—Lisinopril—systemic scleroderma	0.0001	0.000563	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Lisinopril—systemic scleroderma	9.94e-05	0.000559	CcSEcCtD
Conjugated Estrogens—Vomiting—Captopril—systemic scleroderma	9.94e-05	0.000559	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Lisinopril—systemic scleroderma	9.87e-05	0.000555	CcSEcCtD
Conjugated Estrogens—Rash—Captopril—systemic scleroderma	9.86e-05	0.000555	CcSEcCtD
Conjugated Estrogens—Dermatitis—Captopril—systemic scleroderma	9.85e-05	0.000554	CcSEcCtD
Conjugated Estrogens—Somnolence—Lisinopril—systemic scleroderma	9.85e-05	0.000554	CcSEcCtD
Conjugated Estrogens—Headache—Captopril—systemic scleroderma	9.8e-05	0.000551	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Lisinopril—systemic scleroderma	9.75e-05	0.000548	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Mycophenolic acid—systemic scleroderma	9.72e-05	0.000547	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Mycophenolic acid—systemic scleroderma	9.72e-05	0.000547	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	9.7e-05	0.000546	CcSEcCtD
Conjugated Estrogens—Oedema—Mycophenolate mofetil—systemic scleroderma	9.7e-05	0.000546	CcSEcCtD
Conjugated Estrogens—Asthma—Methotrexate—systemic scleroderma	9.67e-05	0.000544	CcSEcCtD
Conjugated Estrogens—Infection—Mycophenolate mofetil—systemic scleroderma	9.64e-05	0.000542	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Lisinopril—systemic scleroderma	9.63e-05	0.000541	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Lisinopril—systemic scleroderma	9.56e-05	0.000538	CcSEcCtD
Conjugated Estrogens—Fatigue—Lisinopril—systemic scleroderma	9.55e-05	0.000537	CcSEcCtD
Conjugated Estrogens—Shock—Mycophenolate mofetil—systemic scleroderma	9.55e-05	0.000537	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	9.52e-05	0.000535	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Leflunomide—systemic scleroderma	9.5e-05	0.000534	CcSEcCtD
Conjugated Estrogens—Pancreatitis—Methotrexate—systemic scleroderma	9.48e-05	0.000533	CcSEcCtD
Conjugated Estrogens—Constipation—Lisinopril—systemic scleroderma	9.47e-05	0.000533	CcSEcCtD
Conjugated Estrogens—Pain—Lisinopril—systemic scleroderma	9.47e-05	0.000533	CcSEcCtD
Conjugated Estrogens—Tachycardia—Mycophenolate mofetil—systemic scleroderma	9.47e-05	0.000533	CcSEcCtD
Conjugated Estrogens—Skin disorder—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.00053	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	9.38e-05	0.000528	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Azathioprine—systemic scleroderma	9.34e-05	0.000525	CcSEcCtD
Conjugated Estrogens—Nausea—Captopril—systemic scleroderma	9.29e-05	0.000522	CcSEcCtD
Conjugated Estrogens—Abdominal discomfort—Methotrexate—systemic scleroderma	9.27e-05	0.000521	CcSEcCtD
Conjugated Estrogens—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.25e-05	0.00052	CcSEcCtD
Conjugated Estrogens—Asthenia—Leflunomide—systemic scleroderma	9.25e-05	0.00052	CcSEcCtD
Conjugated Estrogens—Pruritus—Leflunomide—systemic scleroderma	9.12e-05	0.000513	CcSEcCtD
Conjugated Estrogens—Hypotension—Mycophenolate mofetil—systemic scleroderma	9.07e-05	0.00051	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Lisinopril—systemic scleroderma	9.06e-05	0.000509	CcSEcCtD
Conjugated Estrogens—Dysuria—Methotrexate—systemic scleroderma	9.04e-05	0.000508	CcSEcCtD
Conjugated Estrogens—Dizziness—Azathioprine—systemic scleroderma	9.03e-05	0.000508	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Methotrexate—systemic scleroderma	8.98e-05	0.000505	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	8.84e-05	0.000497	CcSEcCtD
Conjugated Estrogens—Asthenia—Mycophenolic acid—systemic scleroderma	8.82e-05	0.000496	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Leflunomide—systemic scleroderma	8.82e-05	0.000496	CcSEcCtD
Conjugated Estrogens—Urticaria—Lisinopril—systemic scleroderma	8.8e-05	0.000495	CcSEcCtD
Conjugated Estrogens—Insomnia—Mycophenolate mofetil—systemic scleroderma	8.78e-05	0.000494	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Lisinopril—systemic scleroderma	8.76e-05	0.000492	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Lisinopril—systemic scleroderma	8.76e-05	0.000492	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	8.71e-05	0.00049	CcSEcCtD
Conjugated Estrogens—Pruritus—Mycophenolic acid—systemic scleroderma	8.7e-05	0.000489	CcSEcCtD
Conjugated Estrogens—Vomiting—Azathioprine—systemic scleroderma	8.68e-05	0.000488	CcSEcCtD
Conjugated Estrogens—Eye disorder—Prednisone—systemic scleroderma	8.65e-05	0.000487	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	8.65e-05	0.000487	CcSEcCtD
Conjugated Estrogens—Somnolence—Mycophenolate mofetil—systemic scleroderma	8.63e-05	0.000485	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Methotrexate—systemic scleroderma	8.62e-05	0.000485	CcSEcCtD
Conjugated Estrogens—Infestation—Methotrexate—systemic scleroderma	8.62e-05	0.000485	CcSEcCtD
Conjugated Estrogens—Rash—Azathioprine—systemic scleroderma	8.61e-05	0.000484	CcSEcCtD
Conjugated Estrogens—Dermatitis—Azathioprine—systemic scleroderma	8.6e-05	0.000484	CcSEcCtD
Conjugated Estrogens—Depression—Methotrexate—systemic scleroderma	8.59e-05	0.000483	CcSEcCtD
Conjugated Estrogens—Headache—Azathioprine—systemic scleroderma	8.55e-05	0.000481	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	8.54e-05	0.00048	CcSEcCtD
Conjugated Estrogens—Dizziness—Leflunomide—systemic scleroderma	8.52e-05	0.000479	CcSEcCtD
Conjugated Estrogens—Renal failure—Methotrexate—systemic scleroderma	8.47e-05	0.000477	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.44e-05	0.000474	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.41e-05	0.000473	CcSEcCtD
Conjugated Estrogens—Angiopathy—Prednisone—systemic scleroderma	8.4e-05	0.000472	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	8.38e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Prednisone—systemic scleroderma	8.36e-05	0.00047	CcSEcCtD
Conjugated Estrogens—Pain—Mycophenolate mofetil—systemic scleroderma	8.3e-05	0.000467	CcSEcCtD
Conjugated Estrogens—Constipation—Mycophenolate mofetil—systemic scleroderma	8.3e-05	0.000467	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Prednisone—systemic scleroderma	8.27e-05	0.000465	CcSEcCtD
Conjugated Estrogens—Vomiting—Leflunomide—systemic scleroderma	8.2e-05	0.000461	CcSEcCtD
Conjugated Estrogens—Alopecia—Prednisone—systemic scleroderma	8.18e-05	0.00046	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Lisinopril—systemic scleroderma	8.16e-05	0.000459	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Methotrexate—systemic scleroderma	8.15e-05	0.000458	CcSEcCtD
Conjugated Estrogens—Dizziness—Mycophenolic acid—systemic scleroderma	8.13e-05	0.000457	CcSEcCtD
Conjugated Estrogens—Rash—Leflunomide—systemic scleroderma	8.13e-05	0.000457	CcSEcCtD
Conjugated Estrogens—Dermatitis—Leflunomide—systemic scleroderma	8.12e-05	0.000457	CcSEcCtD
Conjugated Estrogens—Mental disorder—Prednisone—systemic scleroderma	8.11e-05	0.000456	CcSEcCtD
Conjugated Estrogens—Nausea—Azathioprine—systemic scleroderma	8.11e-05	0.000456	CcSEcCtD
Conjugated Estrogens—Headache—Leflunomide—systemic scleroderma	8.07e-05	0.000454	CcSEcCtD
Conjugated Estrogens—Malnutrition—Prednisone—systemic scleroderma	8.06e-05	0.000453	CcSEcCtD
Conjugated Estrogens—Erythema—Prednisone—systemic scleroderma	8.06e-05	0.000453	CcSEcCtD
Conjugated Estrogens—Asthenia—Lisinopril—systemic scleroderma	7.95e-05	0.000447	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	7.93e-05	0.000446	CcSEcCtD
Conjugated Estrogens—Pruritus—Lisinopril—systemic scleroderma	7.84e-05	0.000441	CcSEcCtD
Conjugated Estrogens—Vomiting—Mycophenolic acid—systemic scleroderma	7.82e-05	0.00044	CcSEcCtD
Conjugated Estrogens—Rash—Mycophenolic acid—systemic scleroderma	7.75e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Dermatitis—Mycophenolic acid—systemic scleroderma	7.75e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Urticaria—Mycophenolate mofetil—systemic scleroderma	7.71e-05	0.000434	CcSEcCtD
Conjugated Estrogens—Headache—Mycophenolic acid—systemic scleroderma	7.7e-05	0.000433	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Methotrexate—systemic scleroderma	7.68e-05	0.000432	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	7.67e-05	0.000431	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	7.67e-05	0.000431	CcSEcCtD
Conjugated Estrogens—Nausea—Leflunomide—systemic scleroderma	7.66e-05	0.000431	CcSEcCtD
Conjugated Estrogens—Vision blurred—Prednisone—systemic scleroderma	7.6e-05	0.000427	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Lisinopril—systemic scleroderma	7.58e-05	0.000426	CcSEcCtD
Conjugated Estrogens—Visual impairment—Methotrexate—systemic scleroderma	7.46e-05	0.000419	CcSEcCtD
Conjugated Estrogens—Angioedema—Prednisone—systemic scleroderma	7.36e-05	0.000414	CcSEcCtD
Conjugated Estrogens—Dizziness—Lisinopril—systemic scleroderma	7.32e-05	0.000412	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Methotrexate—systemic scleroderma	7.32e-05	0.000411	CcSEcCtD
Conjugated Estrogens—Nausea—Mycophenolic acid—systemic scleroderma	7.3e-05	0.000411	CcSEcCtD
Conjugated Estrogens—Vertigo—Prednisone—systemic scleroderma	7.24e-05	0.000407	CcSEcCtD
Conjugated Estrogens—Eye disorder—Methotrexate—systemic scleroderma	7.23e-05	0.000407	CcSEcCtD
Conjugated Estrogens—Syncope—Prednisone—systemic scleroderma	7.23e-05	0.000406	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Methotrexate—systemic scleroderma	7.18e-05	0.000404	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.15e-05	0.000402	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Prednisone—systemic scleroderma	7.08e-05	0.000398	CcSEcCtD
Conjugated Estrogens—Vomiting—Lisinopril—systemic scleroderma	7.04e-05	0.000396	CcSEcCtD
Conjugated Estrogens—Angiopathy—Methotrexate—systemic scleroderma	7.02e-05	0.000395	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Methotrexate—systemic scleroderma	6.99e-05	0.000393	CcSEcCtD
Conjugated Estrogens—Rash—Lisinopril—systemic scleroderma	6.98e-05	0.000393	CcSEcCtD
Conjugated Estrogens—Convulsion—Prednisone—systemic scleroderma	6.98e-05	0.000393	CcSEcCtD
Conjugated Estrogens—Dermatitis—Lisinopril—systemic scleroderma	6.98e-05	0.000392	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Methotrexate—systemic scleroderma	6.97e-05	0.000392	CcSEcCtD
Conjugated Estrogens—Asthenia—Mycophenolate mofetil—systemic scleroderma	6.96e-05	0.000392	CcSEcCtD
Conjugated Estrogens—Headache—Lisinopril—systemic scleroderma	6.94e-05	0.00039	CcSEcCtD
Conjugated Estrogens—Pruritus—Mycophenolate mofetil—systemic scleroderma	6.87e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Arthralgia—Prednisone—systemic scleroderma	6.86e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Myalgia—Prednisone—systemic scleroderma	6.86e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Anxiety—Prednisone—systemic scleroderma	6.84e-05	0.000385	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—systemic scleroderma	6.84e-05	0.000385	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	6.81e-05	0.000383	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—systemic scleroderma	6.78e-05	0.000381	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—systemic scleroderma	6.74e-05	0.000379	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—systemic scleroderma	6.74e-05	0.000379	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.64e-05	0.000373	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—systemic scleroderma	6.6e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Nausea—Lisinopril—systemic scleroderma	6.58e-05	0.00037	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Prednisone—systemic scleroderma	6.58e-05	0.00037	CcSEcCtD
Conjugated Estrogens—Oedema—Prednisone—systemic scleroderma	6.58e-05	0.00037	CcSEcCtD
Conjugated Estrogens—Infection—Prednisone—systemic scleroderma	6.53e-05	0.000368	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—systemic scleroderma	6.52e-05	0.000366	CcSEcCtD
Conjugated Estrogens—Shock—Prednisone—systemic scleroderma	6.47e-05	0.000364	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Prednisone—systemic scleroderma	6.45e-05	0.000363	CcSEcCtD
Conjugated Estrogens—Tachycardia—Prednisone—systemic scleroderma	6.42e-05	0.000361	CcSEcCtD
Conjugated Estrogens—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.42e-05	0.000361	CcSEcCtD
Conjugated Estrogens—Skin disorder—Prednisone—systemic scleroderma	6.39e-05	0.000359	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Prednisone—systemic scleroderma	6.36e-05	0.000358	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—systemic scleroderma	6.35e-05	0.000357	CcSEcCtD
Conjugated Estrogens—Anorexia—Prednisone—systemic scleroderma	6.27e-05	0.000353	CcSEcCtD
Conjugated Estrogens—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.17e-05	0.000347	CcSEcCtD
Conjugated Estrogens—Rash—Mycophenolate mofetil—systemic scleroderma	6.12e-05	0.000344	CcSEcCtD
Conjugated Estrogens—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.11e-05	0.000344	CcSEcCtD
Conjugated Estrogens—Headache—Mycophenolate mofetil—systemic scleroderma	6.08e-05	0.000342	CcSEcCtD
Conjugated Estrogens—Vertigo—Methotrexate—systemic scleroderma	6.05e-05	0.00034	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Prednisone—systemic scleroderma	5.99e-05	0.000337	CcSEcCtD
Conjugated Estrogens—Insomnia—Prednisone—systemic scleroderma	5.95e-05	0.000335	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Prednisone—systemic scleroderma	5.91e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—systemic scleroderma	5.88e-05	0.000331	CcSEcCtD
Conjugated Estrogens—Convulsion—Methotrexate—systemic scleroderma	5.84e-05	0.000328	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Prednisone—systemic scleroderma	5.79e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Nausea—Mycophenolate mofetil—systemic scleroderma	5.76e-05	0.000324	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—systemic scleroderma	5.73e-05	0.000323	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—systemic scleroderma	5.73e-05	0.000323	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methotrexate—systemic scleroderma	5.73e-05	0.000323	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Prednisone—systemic scleroderma	5.72e-05	0.000322	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	5.69e-05	0.00032	CcSEcCtD
Conjugated Estrogens—Fatigue—Prednisone—systemic scleroderma	5.67e-05	0.000319	CcSEcCtD
Conjugated Estrogens—Constipation—Prednisone—systemic scleroderma	5.62e-05	0.000316	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—systemic scleroderma	5.5e-05	0.000309	CcSEcCtD
Conjugated Estrogens—Infection—Methotrexate—systemic scleroderma	5.46e-05	0.000307	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Methotrexate—systemic scleroderma	5.39e-05	0.000303	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Prednisone—systemic scleroderma	5.38e-05	0.000303	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methotrexate—systemic scleroderma	5.34e-05	0.0003	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—systemic scleroderma	5.31e-05	0.000299	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—systemic scleroderma	5.24e-05	0.000295	CcSEcCtD
Conjugated Estrogens—Urticaria—Prednisone—systemic scleroderma	5.23e-05	0.000294	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Prednisone—systemic scleroderma	5.2e-05	0.000292	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Prednisone—systemic scleroderma	5.2e-05	0.000292	CcSEcCtD
Conjugated Estrogens—Hypotension—Methotrexate—systemic scleroderma	5.14e-05	0.000289	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	5.01e-05	0.000282	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—systemic scleroderma	4.97e-05	0.00028	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—systemic scleroderma	4.94e-05	0.000278	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Methotrexate—systemic scleroderma	4.9e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Somnolence—Methotrexate—systemic scleroderma	4.89e-05	0.000275	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Prednisone—systemic scleroderma	4.85e-05	0.000273	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methotrexate—systemic scleroderma	4.84e-05	0.000272	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Methotrexate—systemic scleroderma	4.78e-05	0.000269	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.75e-05	0.000267	CcSEcCtD
Conjugated Estrogens—Fatigue—Methotrexate—systemic scleroderma	4.74e-05	0.000267	CcSEcCtD
Conjugated Estrogens—Asthenia—Prednisone—systemic scleroderma	4.72e-05	0.000265	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—systemic scleroderma	4.7e-05	0.000264	CcSEcCtD
Conjugated Estrogens—Pruritus—Prednisone—systemic scleroderma	4.65e-05	0.000262	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Prednisone—systemic scleroderma	4.5e-05	0.000253	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.5e-05	0.000253	CcSEcCtD
Conjugated Estrogens—Urticaria—Methotrexate—systemic scleroderma	4.37e-05	0.000246	CcSEcCtD
Conjugated Estrogens—Dizziness—Prednisone—systemic scleroderma	4.35e-05	0.000245	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methotrexate—systemic scleroderma	4.35e-05	0.000244	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—systemic scleroderma	4.35e-05	0.000244	CcSEcCtD
Conjugated Estrogens—Vomiting—Prednisone—systemic scleroderma	4.18e-05	0.000235	CcSEcCtD
Conjugated Estrogens—Rash—Prednisone—systemic scleroderma	4.15e-05	0.000233	CcSEcCtD
Conjugated Estrogens—Dermatitis—Prednisone—systemic scleroderma	4.14e-05	0.000233	CcSEcCtD
Conjugated Estrogens—Headache—Prednisone—systemic scleroderma	4.12e-05	0.000232	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Methotrexate—systemic scleroderma	4.05e-05	0.000228	CcSEcCtD
Conjugated Estrogens—Asthenia—Methotrexate—systemic scleroderma	3.94e-05	0.000222	CcSEcCtD
Conjugated Estrogens—Nausea—Prednisone—systemic scleroderma	3.91e-05	0.00022	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—systemic scleroderma	3.89e-05	0.000219	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methotrexate—systemic scleroderma	3.76e-05	0.000212	CcSEcCtD
Conjugated Estrogens—Dizziness—Methotrexate—systemic scleroderma	3.64e-05	0.000204	CcSEcCtD
Conjugated Estrogens—Vomiting—Methotrexate—systemic scleroderma	3.5e-05	0.000197	CcSEcCtD
Conjugated Estrogens—Rash—Methotrexate—systemic scleroderma	3.47e-05	0.000195	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—systemic scleroderma	3.46e-05	0.000195	CcSEcCtD
Conjugated Estrogens—Headache—Methotrexate—systemic scleroderma	3.44e-05	0.000194	CcSEcCtD
Conjugated Estrogens—Nausea—Methotrexate—systemic scleroderma	3.27e-05	0.000184	CcSEcCtD
